US health authorities have suspended the license for the Ixchiq vaccine against the chikungunya virus following reports of “serious adverse events,” the vaccine’s French manufacturer Valneva announced on Monday. Ixchiq, one of only two vaccines approved by the US Food and Drug Administration (FDA) for the mosquito-borne virus, was granted approval in 2023. However, safety … Continue reading US Suspends Chikungunya Vaccine Following Reports Of Severe Reactions